Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statistical considerations in pharmacokinetic study design

J D Powers1

  • 1Department of Veterinary Clinical Sciences and Statistics, Ohio State University, Columbus.

Clinical Pharmacokinetics
|May 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient Portal Use Near the End-of-Life.

Journal of general internal medicine·2021
Same author

The predicted role of steric specificity in crowding-mediated effects on reversible biomolecular association.

Physical biology·2015
Same author

Predictors of a child's ability to use a visual analogue scale.

Child: care, health and development·2003
Same author

Statistical comparison of dissolution curves.

Pharmacological research·2001
Same author

On the determination of bioequivalence.

Pharmacological research·1999
Same author

Prilocaine-phenylephrine topical anesthesia for repair of mucous membrane lacerations.

Pediatric emergency care·1998
Same journal

Population Pharmacokinetic Modelling of Dolutegravir: A Narrative Review.

Clinical pharmacokinetics·2026
Same journal

Partial Area Under the Curve: A Revelatory Story in Pharmacokinetics.

Clinical pharmacokinetics·2026
Same journal

Informing Sampling Design for Lung Distribution Studies Using a Pulmonary Population Minimal PBPK Model.

Clinical pharmacokinetics·2026
Same journal

Revisited Pharmacokinetic Profiles of Methylprednisolone in Plasma and Urine After Single and Multiple Oral Administrations: Relevance in Sports Drug Testing.

Clinical pharmacokinetics·2026
Same journal

ALBI Grade is a Determinant of Lenvatinib Pharmacokinetics, Efficacy, and Toxicities in Japanese Patients with Hepatocellular Carcinoma.

Clinical pharmacokinetics·2026
Same journal

Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer.

Clinical pharmacokinetics·2026
See all related articles

This study categorizes pharmacokinetic research into population-based and individual-based methods. Population-based studies offer flexibility in patient selection and sampling times, making them adaptable for clinical settings.

Area of Science:

  • Pharmacokinetics
  • Clinical Pharmacology
  • Drug Development

Background:

  • Pharmacokinetic (PK) studies are crucial for understanding drug behavior in the body.
  • Existing PK study designs include population-based, individual-based compartmental, and individual-based noncompartmental approaches.
  • Each PK study type presents unique advantages and limitations.

Purpose of the Study:

  • To delineate the characteristics and applications of different pharmacokinetic study designs.
  • To highlight the benefits of population-based pharmacokinetic studies in clinical practice.
  • To compare individual-based compartmental and noncompartmental analyses.

Main Methods:

  • Categorization of pharmacokinetic studies into three main types: population-based, individual-based compartmental, and individual-based noncompartmental.

Related Experiment Videos

  • Discussion of the advantages and limitations of each study type.
  • Mention of NONMEM software for population-based data evaluation and a novel method for deriving individual estimates.

    • Main Results:

    • Population-based studies offer flexibility in sampling times and patient inclusion (critically ill, geriatric, pediatric), adaptable to clinical settings.
    • Individual-based studies are divided into compartmental and noncompartmental, with noncompartmental analyses found to be more restrictive.
    • Noncompartmental analyses can yield parameters like Area Under the Moment Curve (AUMC) and Mean Residence Time (MRT).

    Conclusions:

    • Population-based pharmacokinetic studies are valuable for clinical settings due to their adaptability and flexibility.
    • Combining population-based data analysis with individual estimation methods can aid in dosage regimen adjustments.
    • Understanding the nuances of different PK study designs is essential for effective drug therapy management.